These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5385567)

  • 1. [Practical value of various methods of registering B.S.P. clearance curves].
    Lemonnier F; Julien C; Valleron A; Chevrel B; Caroli J
    Rev Med Chir Mal Foie; 1969; 44(2):85-8. PubMed ID: 5385567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic clearance of sulfobromophthalein administered in small doses in subjects with hepatobiliary diseases].
    Cravario A; Molino G; Giangrandi E
    Minerva Gastroenterol; 1966; 12(4):135-41. PubMed ID: 5993623
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors influencing the clearance of B.S.P.: urinary elimination of B.S.P].
    Toulet J; Rousselet J; Lunel J; Albot G
    Rev Int Hepatol; 1968; 18(4):565-90. PubMed ID: 5688213
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clearance of sulfobromophthalein (B.S.F.) in pediatrics].
    Acta Gastroenterol Latinoam; 1972; 4(4):191-2. PubMed ID: 4664516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlative study of B.S.P. clearances by use of the K1-K2 diagram].
    Toulet J; Albot G; Lunel J; Davezac JF
    Rev Int Hepatol; 1968; 18(4):533-6. PubMed ID: 5688211
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factors influencing blood clearance of B.S.P. and their practical consequences. General considerations and field of application].
    Toulet J
    Rev Int Hepatol; 1968; 18(4):525-31. PubMed ID: 5700026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of the determination of serum ornithine-carbamoyl transferase and of sulfobromophthalein clearance in the laboratory diagnosis of chronic liver diseases].
    Ceriotti G; Zotti S; Bonini PA
    Quad Sclavo Diagn; 1971 Dec; 7(4):1192-212. PubMed ID: 5161741
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical value of the fractional clearance of BSP in hepatic functional exploration and in diagnosis of chronic liver diseases].
    Oancea R; Suman S; Filip V; Macarie O; Ciocan A
    Med Interna (Bucur); 1966 Oct; 18(10):1233-40. PubMed ID: 5978450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental and clinical studies using I-131 BSP].
    Mostbeck A; Peschl L; Rettenbacher-Täubner H; Neumayr A
    Z Gastroenterol; 1974 Nov; 12(7):547-56. PubMed ID: 4440045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bromosulphalein clearance in the elderly].
    Tuchszer S; Levin H; Fiszlejder L; Schcolnicov B; Rigilo R; Kramer FO
    Prensa Med Argent; 1969 Sep; 56(29):1437-41. PubMed ID: 5381884
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the B.S.P. and radiogold clearance techniques in estimating the hepatic blood flow in hepatosplenic bilharziasis.
    Mousa AH; el-Garem A; el-Rooby A; Saif M; Zein el-Abdine A
    J Egypt Med Assoc; 1966; 49(1):33-40. PubMed ID: 5959533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver functional exploration in the dog, the BSP test].
    Moraillon R; Joncourt A; Lafage P
    Bull Acad Vet Fr; 1971 Apr; 44(4):203-14. PubMed ID: 5167471
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifamycin SV clearance as hepatic functional test. Comparison with the bromsulphalein clearance.
    Laudano OM; Cifarelli C; Brasca A; Mercol E
    Rev Int Hepatol; 1967; 17(5):423-8. PubMed ID: 6056143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clearance of bromsulphthalein in the liver function test].
    Matusan J; Dujmović M
    Lijec Vjesn; 1967 Jul; 89(7):525-32. PubMed ID: 5592127
    [No Abstract]   [Full Text] [Related]  

  • 17. [A modification of the micromethod of the excretory function of the liver].
    Tugarinova VN; Miklashevskiĭ VE; Skobtsova GG
    Lab Delo; 1967; 4():218-20. PubMed ID: 4180752
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymptomatic liver disease in Australia-antigen-positive blood donors.
    Woolf IL; Boyes BE; Dymock IW; Renton PH; Stratton F
    Gut; 1972 Oct; 13(10):852. PubMed ID: 5087112
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retention and "clearance" of bromosulphthalein. Technic, indications and results].
    Andres Bellomo J
    Prensa Med Argent; 1969 Mar; 56(3):108-17. PubMed ID: 5809563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulfobromophthalein test in infancy].
    Donath A; Eduah S; Colombo JP
    Helv Paediatr Acta; 1970 Dec; 25(6):634-46. PubMed ID: 5515945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.